XML 42 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule Of Fair Values Of The Company's Derivative Instruments And The Line Items On The Consolidated Balance Sheets
The fair values of the Company’s derivative instruments and the line items on the consolidated balance sheets to which they were recorded as of December 31, 2017, and 2016, are summarized as follows:
 
 
Balance Sheets
Location
 
December 31,
 
Balance Sheets
Location
 
December 31,
2017
2016
2017
2016
 
 
(In thousands)
 
 
 
(In thousands)
Derivative contracts not designated as hedging instruments
 
Prepaid expenses and other current assets
 
$
1,314

$
5,873

 
Other accrued liabilities
 
$
7,128

$
1,002

Derivative contracts designated as hedging instruments
 
Prepaid expenses and other current assets
 
485

2,890

 
Other accrued liabilities
 
1,064

703

Total
 
 
 
$
1,799

$
8,763

 
 
 
$
8,192

$
1,705


Schedule of Offsetting of Derivative Assets
The following tables set forth the offsetting of derivative assets as of December 31, 2017 and 2016:
As of December 31, 2017
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Consolidated Balance Sheets
 
Net Amounts Of Assets Presented in the Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
 
 
(In thousands)
Bank of America

 
$
1,664

 
$

 
$
1,664

 
$
(1,664
)
 
$

 
$

Wells Fargo
 
135

 

 
135

 
(135
)
 

 

Total
 
$
1,799

 
$

 
$
1,799

 
$
(1,799
)
 
$

 
$

As of December 31, 2016
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Consolidated Balance Sheets
 
Net Amounts Of Assets Presented in the Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
 
 
(In thousands)
J.P. Morgan Chase
 
$
1,492

 
$

 
$
1,492

 
$
(442
)
 
$

 
$
1,050

Wells Fargo
 
7,271

 

 
7,271

 
(1,263
)
 

 
6,008

Total
 
$
8,763

 
$

 
$
8,763

 
$
(1,705
)
 
$

 
$
7,058

Schedule of Offsetting of Derivative Liabilities
The following tables set forth the offsetting of derivative liabilities as of December 31, 2017 and 2016:
As of December 31, 2017
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Consolidated Balance Sheets
 
Net Amounts Of Liabilities Presented in the Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
 
 
(In thousands)
Bank of America

 
$
7,815

 
$

 
$
7,815

 
$
(1,664
)
 
$

 
$
6,151

Wells Fargo
 
377

 

 
377

 
(135
)
 

 
242

Total
 
$
8,192

 
$

 
$
8,192

 
$
(1,799
)
 
$

 
$
6,393

As of December 31, 2016
 
 
 
 
 
 
 
Gross Amounts Not Offset in the Consolidated Balance Sheets
 
 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Consolidated Balance Sheets
 
Net Amounts Of Liabilities Presented in the Consolidated Balance Sheets
 
Financial Instruments
 
Cash Collateral Pledged
 
Net Amount
 
 
(In thousands)
J.P. Morgan Chase
 
$
442

 
$

 
$
442

 
$
(442
)
 
$

 
$

Wells Fargo
 
1,263

 

 
1,263

 
(1,263
)
 

 

Total
 
$
1,705

 
$

 
$
1,705

 
$
(1,705
)
 
$

 
$

Schedule Of Company's Derivative Instruments On Other Comprehensive Income And The Consolidated Statement Of Operations
The pre-tax effects of the Company’s derivative instruments on OCI and the consolidated statements of operations for the years ended December 31, 2017, 2016 and 2015 are summarized as follows:
Derivatives Designated as
Hedging Instruments
 
Year Ended December 31, 2017
 
Gains (Losses) 
Recognized in
OCI -
Effective
Portion
 
Location of
Gains (Losses)
Reclassified from OCI
into Income - Effective
Portion
 
Gains (Losses)
Reclassified
from
OCI into
Income -
Effective
Portion (1)
 
Location of
Gains (Losses)
Recognized in
Income and
Excluded from
Effectiveness  Testing
 
Amount of Gains (Losses) Recognized in
Income and
Excluded from
Effectiveness  Testing
 
 
(In thousands)
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
(10,692
)
 
Net revenue
 
$
(8,693
)
 
Other income (expense), net
 
$
1,587

Foreign currency forward contracts
 

 
Cost of revenue
 
18

 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
1,051

 
Other income (expense), net
 

Total
 
$
(10,692
)
 
 
 
$
(7,624
)
 
 
 
$
1,587

_________________________
(1)     Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.


Derivatives Designated as
Hedging Instruments
 
Year Ended December 31, 2016
 
Gains (Losses) 
Recognized in
OCI -
Effective
Portion
 
Location of
Gains (Losses)
Reclassified from OCI
into Income - Effective
Portion
 
Gains (Losses)
Reclassified
from
OCI into
Income -
Effective
Portion (1)
 
Location of
Gains (Losses)
Recognized in
Income and
Excluded from
Effectiveness  Testing
 
Amount of Gains (Losses) Recognized in
Income and
Excluded from
Effectiveness  Testing
 
 
(In thousands)
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
3,007

 
Net revenue
 
$
1,100

 
Other income (expense), net
 
$
365

Foreign currency forward contracts
 

 
Cost of revenue
 
(6
)
 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
(274
)
 
Other income (expense), net
 

Total
 
$
3,007

 
 
 
$
820

 
 
 
$
365

_________________________
(1)  
Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.
Derivatives Designated as
Hedging Instruments
 
Year Ended December 31, 2015
 
Gains (Losses) 
Recognized in
OCI -
Effective
Portion
 
Location of
Gains (Losses)
Reclassified from OCI
into Income - Effective
Portion
 
Gains (Losses)
Reclassified
from
OCI into
Income -
Effective
Portion (1)
 
Location of
Gains (Losses)
Recognized in
Income and
Excluded from
Effectiveness  Testing
 
Amount of Gains (Losses) Recognized in
Income and
Excluded from
Effectiveness  Testing
 
 
(In thousands)
Cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Foreign currency forward contracts
 
$
453

 
Net revenue
 
$
462

 
Other income (expense), net
 
$
(52
)
Foreign currency forward contracts
 

 
Cost of revenue
 
6

 
Other income (expense), net
 

Foreign currency forward contracts
 

 
Operating expenses
 
(15
)
 
Other income (expense), net
 

Total
 
$
453

 
 
 
$
453

 
 
 
$
(52
)
_________________________
(1)  
Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.
Schedule Of Derivatives Not Designated As Hedging Instruments
The effects of the Company’s derivatives not designated as hedging instruments in other income (expense), net in the consolidated statements of operations for the years ended December 31, 2017, 2016 and 2015, are as follows:
 
 
 
Year ended December 31,
Derivatives Not Designated as Hedging Instruments
 
Location of Gains (Losses)
Recognized in Income on Derivative
2017
2016
2015
 
 
 
(In thousands)
Foreign currency forward contracts
 
Other income (expense), net
(6,945
)
3,789

$
4,956